PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Eleni Gavriilaki(Aristotle University of Thessaloniki), Ioanna Sakellari(G. Papanikolaou General Hospital), Nikolaos Spyridis(G. Papanikolaou General Hospital), F. Mouladeniou(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Apostolia Papalexandri(G. Papanikolaou General Hospital), Marianna Masmanidou(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Chrysavgi Lalayanni(G. Papanikolaou General Hospital), G Pistiolas(G. Papanikolaou General Hospital), Anna Vardi(G. Papanikolaou General Hospital), C. Vadikoliou(G. Papanikolaou General Hospital), George Karavalakis(G. Papanikolaou General Hospital), A. Panteliadou(G. Papanikolaou General Hospital), D. Mallouri(G. Papanikolaou General Hospital), Tasoula Touloumenidou(G. Papanikolaou General Hospital), E. Yannaki(Theageneio General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
|Blood|2013|93
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63